Treatment of anemia of chronic kidney disease
References (24)
- et al.
High Creactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
Am J Kidney Dis
(1997) - et al.
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
Am J Kidney Dis
(1999) - et al.
ACE inhibitors do not induce recombinant erythropoietin resistance in hemodialysis patients
Am J Kidney Dis
(2000) - et al.
Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity
Kidney Int
(2000) - et al.
Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin
Am J Kidney Dis
(1999) Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure
Pediatr Nephrol
(1995)- et al.
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity-The experience of the Lombardy Dialysis Registry [news]
Nephrol Dial Transplant
(1998) - et al.
Hematocrit level and associated mortality in hemodialysis patients
J Am Soc Nephrol
(1999) - et al.
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and Epoetin
N Engl J Med
(1998) - et al.
Hematocrit levels and hospitalization risks in hemodialysis patients
J Am Soc Nephrol
(1999)
Physical performance and associated electrolyte changes after haemoglobin normalization: A comparative study in haemodialysis patients
Nephrol Dial Transplant
(1999)
Normalizing hematocrit in dialysis patients improves brain function
Am J Kidney Dis
(1999)
Cited by (0)
Copyright © 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.